Metastatic Hormone Refractory Prostate Cancer Recruiting Phase Trials for Goserelin (DB00014)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

IndicationStatusPhase
DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03867357Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia